INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 45h ago
HOUSE PTR5h ago
SEC 13F5h ago
ROBINHOOD CHAIN5h ago
HOUSE PTR/PurchaseVerified data

Tim Moore bought GNPX

Self · Genprex, Inc. · Genprex, Inc. - Common Stock

Side
BUY
Value range
$1,001 – $15K
Shares
Not disclosed
Price
—
Executed
Feb 5, 2026
Disclosed
Feb 20, 2026
Disclosure timeline15 days from execution to publication · legal deadline 45 days
Feb 5 executedFeb 20, 2026 disclosed

GNPX · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
24/ 100 · ROUTINE
Methodology →
  • Transaction type+14 / 20

    Purchase

  • Relative size+2 / 25

    Disclosed range starting at $1K

  • Filing timing0 / 15

    Disclosed 15 days after execution (STOCK Act deadline: 45)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

  • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · GNPX

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    21
    LM
    Longnecker Brent MDirector
    GNPXGenprex, Inc.
    Open-market sale
    SELL$9.84
    8 sh
    Apr 14, 2026Apr 15, 2026
    traded Apr 14, 2026
    +1dSEC FORM 4

    Evidence

    33
    LM
    Longnecker Brent MDirector
    GNPXGenprex, Inc.
    Open-market sale
    SELL$12.3
    10 sh
    Apr 14, 2026Apr 15, 2026
    traded Apr 14, 2026
    +1dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    House Periodic Transaction Report
    Publisher
    Clerk of the U.S. House of Representatives
    Document ID
    20034034

    Timestamps

    Event (reported)
    Feb 5, 2026
    Published
    Feb 20, 2026
    Ingested by INSIDER
    Nov 5, 06:47 UTC
    Last re-read
    Nov 5, 06:47 UTC

    Extracted facts

    Filer
    Tim Moore
    Role
    Self
    Transaction
    PurchaseAs filed: “P”
    Asset
    Genprex, Inc. - Common Stock
    Ticker
    GNPX
    Reported value
    $1,001 – $15KAs filed: “$1,001 - $15,000”
    Execution date (reported)
    Feb 5, 2026
    Notification date (reported)
    Feb 5, 2026
    Days from execution to publication
    15

    Calculation

    Midpoint = (low + high) / 2. Used only to rank and sum ranges; the true value can be anywhere in the range.

    • Low: $1,001
    • High: $15,000

    = $8,001

    What this establishes

    Tim Moore reported a purchase of Genprex, Inc. - Common Stock. Members report a value range, not an exact amount, and do not report share counts or prices. Dates are as entered by the filer. A trade report is not evidence of wrongdoing.

    Extraction

    Method
    PDF text extraction
    Confidence
    1.00
    Self
    Tim Moorebioguide:M001236
    Issuer
    Genprex, Inc.cik:0001595248

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.